
Stanley Szefler MD
Pediatric Asthma & Allergic Conditions
Professor of Pediatrics, University of Colorado Denver
Join to View Full Profile
13123 E 16th AveAurora, CO 80045
Phone+1 720-777-1234
Fax+1 720-777-7284
Dr. Szefler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Stanley Szefler, based in Aurora, CO, specializes in Allergy & Immunology with a subspecialty in Pediatric Asthma & Allergic Conditions. He completed his medical education and training at the University at Buffalo and is the Director of Pediatric Asthma Research at Children's Hospital Colorado. Dr. Szefler has expertise in chronic obstructive pulmonary disease and pediatric asthma, contributing significantly to the field through numerous publications, including work in digital health for asthma management. He is also involved in clinical trials focused on respiratory illnesses in children including the development and implementation of a school-based asthma program in Colorado. Dr. Szefler has received several honors, including the Summer Yaffe Lifetime Achievement Award and has served as a visiting professor at prominent universities.
Education & Training
Women and Children's Hospital of BuffaloFellowship, Clinical Pharmacology, 1977 - 1979
University at BuffaloResidency, Pediatrics, 1975 - 1977
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1975
School of Pharmacy, State University of New York at BuffaloB.S., Pharmacy, Magna Cum Laude, 1968 - 1971
Canisius CollegeNo Degree, 1966 - 1968
Certifications & Licensure
NY State Medical License 1977 - Present
CO State Medical License 1982 - 2027
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Leadership Award Kappa Psi, 0
- Summer Yaffe Lifetime Achievement Award Pediatric Pharmacy Advocacy Group, 2016
- Visiting Professor University of Iowa, 2015
- Join now to see all
Clinical Trials
- Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) Start of enrollment: 1991 Sep 01
- Prevention of Early Asthma in Kids (PEAK) Start of enrollment: 2001 Jan 01
- Pediatric Asthma Controller Trial (PACT) Start of enrollment: 2002 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- Emerging systemic treatments for asthma and allergic diseases: New tricks, same dog?Alessandra Tomasello, Stanley J Szefler, Katherine N Cahill
The Journal of Allergy and Clinical Immunology. in Practice. 2025-09-03 - 1 citationsUshering in the Era of Corticosteroid Stewardship: What Is the Impact of Biologics on This Asthma Burden?Stanley J Szefler, William W Busse
The Journal of Allergy and Clinical Immunology. in Practice. 2025-08-01 - 1 citationsOscillometry Measures the Response to Acute Asthma Therapy in the Pediatric Emergency Department.Nidhya Navanandan, Ella Hagopian, John T Brinton, Melisa Tanverdi, Alec Edid
Annals of the American Thoracic Society. 2025-07-24
Journal Articles
- Rostrum What Is the Role of Increasing Inhaled Corticosteroid Therapy in Worsening Asthma in Children?Stanley Szefler, MD, ScienceDirect
- Original Article Phenotypes of Recurrent Wheezing in Preschool Children: Identification by Latent Class Analysis and Utility in Prediction of Future ExacerbationWayne Morgan, Daniel J Jackson, Michael D Cabana, Avraham Beigelman, Leonard B Bacharier, Stanley J Szefler, ScienceDirect
- Advances in asthma 2015: across the lifespanLiu AH, Anderson III WC, Dutmr CM, Searing DA, Szefler SJ, J Allergy Clin Immunol, 1/1/2016
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Severe asthma in pediatric patients. Pathophysiology and unmet needs.Dunn R, Szefler SJ, Annals ATS, 1/1/2016
- Once-daily tiotropium Respimat add-on therapy improves FEF 25-75% in children and adolescent patients with persistent symptomatic asthma.Goldstein S, Szefler SJ, Vogelberg C, Bensch G, Given J, El Azzi G, Monroni-Zentgraf P, Engel M, Sigmund R, Hamelmann E, Am J Respir Crit Care Med, 1/1/2016
- Once-daily tiotropium Respimat add-on therapy improves lung function in children with severe symptomatic asthma.Szefler SJ, Harper T, Laki I, Boner A, El Azzi G, Moroni-Zentgraf P, Engel M, Hayman A, Hamelmann E, Am J Respir Crit Care Med, 1/1/2016
- Join now to see all
Lectures
- "Implications of reduced lung growth on long term asthma outcomes"Granby, CO - 1/1/2016
- "Cross-age studies: Important decisions"Los Angeles, CA - 1/1/2016
- Barriers to Asthma Management in SchoolsLos Angeles, CA - 1/1/2016
- Join now to see all
Other
- Pharmacotherapy of asthmaSzefler SJ, NICHD Webinar
1/1/2016 - Pulmicort Turbuhaler: Clinical Product MonographBusse WW, Bleeker ER, Creticos PS, Kemp JP, Sullivan SD, Szefler SJ, Weiss KB, OCC (Publisher)
Oxford - 1/1/1998 - Glucocorticoids.Szefler SJ, American Thoracic Society-Up-To-Date Series, CD-ROM Program
1/1/1996 - Join now to see all
Press Mentions
Researchers Concerned About Proposal for OTC Rescue Inhaler AvailabilityJuly 21st, 2022
Lebrikizumab Shows Promise in Adolescents with Uncontrolled AsthmaMay 18th, 2022
“A Huge, Huge, Huge Help”: Children’s Hospital Program for Kids with Severe Asthma Expands Beyond Denver-Area SchoolsMay 2nd, 2021- Join now to see all
Professional Memberships
- Fellow
- Fellow
- Member
- Member
- American College of Allergy, Asthma and ImmunologyFellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









